2,3-dinor-thromboxane b2 has been researched along with Proteinuria in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maeda, K; Niwa, T; Shibata, M; Yamada, K | 1 |
1 other study(ies) available for 2,3-dinor-thromboxane b2 and Proteinuria
Article | Year |
---|---|
Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
Topics: 6-Ketoprostaglandin F1 alpha; Acrylates; Adolescent; Adult; Aged; Female; Glomerulonephritis; Humans; Male; Methacrylates; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Proteinuria; Thromboxane B2; Thromboxane-A Synthase | 1988 |